3-(1-Methyl-7-Oxo-3-Propyl-4,7-Dihydro-1H-Pyrazolo[4,3-D]Pyrimidin-5-Yl)-N-[2-(1-Methylpyrrolidin-2-Yl)Ethyl]-4-Propoxybenzenesulfonamide; 3-(6,7-Dihydro-1-Methyl-7-Oxo-3-Propyl-1H-Pyrazolo[4,3-D]Pyrimidin-5-Yl)-N-[2-(1-Methyl-2-Pyrrolidinyl)Ethyl]-4-Propoxybenzenesulfonamide; 5-(2-Propyloxy-5-(1-Methyl-2-Pyrollidinylethylamidosulfonyl)Phenyl)-1-Methyl-3-Propyl-1,6-Dihydro-7H-Pyrazolo(4,3-D)Pyrimidine-7-One; 5-[2-Propyloxy-5-[2-(1-Methyl-2-Pyrrolidinyl)Ethylaminosulfonyl]Phenyl]-1-Methyl-3-Propyl-1,6-Dihydro-7H-Pyrazolo[4,3-D]Pyrimidine-7-One; 5-[2-Propyloxy-5-(2-(1-Methylpyrrolidin-2-Yl)Ethylaminosulphonyl)Phenyl]-1-Methyl-3-Propyl-6,7-Dihydro-1H-Pyrazolo(4,3-D)Pyrimidin-7-One; Zydena; Da-8159; Udenafil-D7

Brief Introduction

Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and will be marketed under the brand name Zydena. It is not yet approved for use in the U.S., E.U., or Canada.

Omacetaxine Mepesuccinate

MSDS

CAS:26833-87-4

Molecular Formula:C29H39NO9

Alias

More Information

Hmoharringtonine; Ceflatonin; Homobarringtonie; Homoharringtonine; Hht; Myelostat; Homoharringtonin; Homoharringtoninum; Cgx 635; Homoharrigtonine; Synribo

Brief Introduction

Homoharringtonine mainly inhibits DNA and protein synthesis of leukemia cells, dissolves and necrosis of nuclei, and obvious nucleolar lesions. It can also inhibit and damage G2 phase cells, so that most G2 phase cells enter M phase and are inhibited. It is a cell cycle nonspecific drug. It is used for the treatment of acute monocytic leukemia, acute myeloid leukemia, acute promyelocytic leukocyte and erythroleukoma, acute myeloid leukemia and malignant lymphoma. It also has a certain effect on malignant lymphoma, polycythemia vera and other types of leukemia.

Benzylhydroxylamine Hydrochloride

MSDS

CAS:2687-43-6

Molecular Formula:C7H10ClNO

Alias

More Information

Benzyloxyamine; Benzyloxyamine Hcl; O-Benzylhydroxylamine Hcl; O-Benzylhydroxylamine Hydrochloride; Benzyloxyammonium Chloride; 2-Benzylhydroxylaminehcl; Benzylhydroxylamine Hcl; Hydroxylamine, O-(Phenylmethyl)-, Hydrochloride; Phenylmethoxyamine Hydrochloride; O-Benzylhydroxylammonium Chloride; Labotest-Bb Lt00233131; Benzyloxyamine Hydrochloride; Timtec-Bb Sbb003971

Brief Introduction

Benzyloxyamine hydrochloride is a reagent for the synthesis of hydroxylamine and hydroxylamine.

1-(3-Hydroxy-4,7,7-Trimethyl-2-Bicyclo[2.2.1]Heptanyl)-3-(4-Methylphenyl)Sulfonylurea

MSDS

CAS:26944-48-9

Molecular Formula:C18H26N2O4S

Alias

More Information

1-((1R)-2Endo-Hydroxy-Bornan-3Endo-Yl)-3-(Toluene-4-Sulfonyl)-Urea; 1-(P-Tolylsulfonyl)-3-(2-Endo-Hydroxy-3-Endo-D-Bornyl)Harnstoff; 1-(P-Tolylsulfonyl)-3-(2-Endo-Hydroxy-3-Endo-L-Bornyl)Harnstoff; Glibornurida [Inn-Spanish]; Einecs 248-124-6; 1-((1R)-2-Endo-Hydroxy-3-Endo-Bornyl)-3-(P-Tolylsulfonyl)Urea; Ro 6-4563; Glibornuride; Endo,Endo-1-((1R)-(2-Hydroxy-3-Bornyl))-3-(P-Tolylsulfonyl)Urea; Glibornuridum [Inn-Latin]; Glutril; Ro 6-4563/8

Brief Introduction

This product is a sulfonylurea hypoglycemic drug. The effect is similar to that of tolbutamide, but the curative effect is 20 times stronger than that of tolbutamide. In addition to stimulating islets β- In addition to insulin secretion, cells can also reduce platelet aggregation, reduce blood viscosity, increase prostacyclin and reduce thromboxane A2 in blood, which is conducive to maintaining the normal structure and function of platelets and arteries and improving microcirculation, but it has no significant effect on cholesterol and triglycerides in blood. For non-insulin-dependent diabetes mellitus, it is more suitable for adults over 40 years of age.

4-Acetyloxybutanoic Acid

MSDS

CAS:26976-72-7

Molecular Formula:C6H10O4

Alias

More Information

4-Acetoxy-Buttersaeure; Unii-F777Xep0Ll; 4-Acetoxy-N-Butyric Acid; Butanoic Acid,4-(Acetyloxy); 4-Acetoxy-Butyric Acid; 4-(Acetyloxy)Butanoic Acid; Aceburic Acid

Brief Introduction

The molecular formula of 4-acetyloxybutanoic acid is C6H10O4.

Inquiry (

/ 10

)

Clear All